AU669477B2 - Process for massive conversion of clostridia into synchronized cells of critical length or refractile endospores - Google Patents
Process for massive conversion of clostridia into synchronized cells of critical length or refractile endospores Download PDFInfo
- Publication number
- AU669477B2 AU669477B2 AU12422/92A AU1242292A AU669477B2 AU 669477 B2 AU669477 B2 AU 669477B2 AU 12422/92 A AU12422/92 A AU 12422/92A AU 1242292 A AU1242292 A AU 1242292A AU 669477 B2 AU669477 B2 AU 669477B2
- Authority
- AU
- Australia
- Prior art keywords
- cells
- subculture
- growth medium
- process according
- batch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000034 method Methods 0.000 title claims description 87
- 230000001360 synchronised effect Effects 0.000 title claims description 50
- 230000008569 process Effects 0.000 title claims description 39
- 241001112696 Clostridia Species 0.000 title description 7
- 238000006243 chemical reaction Methods 0.000 title description 4
- 239000002904 solvent Substances 0.000 claims description 67
- 239000001963 growth medium Substances 0.000 claims description 66
- 230000012010 growth Effects 0.000 claims description 41
- 238000011534 incubation Methods 0.000 claims description 40
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 37
- 229910052799 carbon Inorganic materials 0.000 claims description 37
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 34
- 229960005069 calcium Drugs 0.000 claims description 34
- 239000011575 calcium Substances 0.000 claims description 34
- 229910052791 calcium Inorganic materials 0.000 claims description 34
- 230000032823 cell division Effects 0.000 claims description 32
- 150000001768 cations Chemical class 0.000 claims description 31
- 229920001221 xylan Polymers 0.000 claims description 30
- 150000004823 xylans Chemical class 0.000 claims description 30
- 238000004519 manufacturing process Methods 0.000 claims description 22
- 230000001580 bacterial effect Effects 0.000 claims description 21
- 238000010348 incorporation Methods 0.000 claims description 21
- 239000002609 medium Substances 0.000 claims description 21
- 241000193403 Clostridium Species 0.000 claims description 20
- 239000003242 anti bacterial agent Substances 0.000 claims description 19
- 229940088710 antibiotic agent Drugs 0.000 claims description 19
- 241000894006 Bacteria Species 0.000 claims description 18
- 102000004169 proteins and genes Human genes 0.000 claims description 18
- 108090000623 proteins and genes Proteins 0.000 claims description 18
- 108090000790 Enzymes Proteins 0.000 claims description 17
- 102000004190 Enzymes Human genes 0.000 claims description 17
- 239000004227 calcium gluconate Substances 0.000 claims description 16
- 229960004494 calcium gluconate Drugs 0.000 claims description 16
- 235000013927 calcium gluconate Nutrition 0.000 claims description 16
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical group [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 16
- 230000001965 increasing effect Effects 0.000 claims description 16
- 239000007795 chemical reaction product Substances 0.000 claims description 15
- 239000000047 product Substances 0.000 claims description 15
- 241000894007 species Species 0.000 claims description 14
- 230000002503 metabolic effect Effects 0.000 claims description 11
- 238000005119 centrifugation Methods 0.000 claims description 9
- 229960000210 nalidixic acid Drugs 0.000 claims description 9
- MHWLWQUZZRMNGJ-UHFFFAOYSA-N nalidixic acid Chemical compound C1=C(C)N=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 MHWLWQUZZRMNGJ-UHFFFAOYSA-N 0.000 claims description 9
- 230000001413 cellular effect Effects 0.000 claims description 8
- 231100000331 toxic Toxicity 0.000 claims description 8
- 230000002588 toxic effect Effects 0.000 claims description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 claims description 7
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 6
- 239000005662 Paraffin oil Substances 0.000 claims description 6
- 239000004599 antimicrobial Substances 0.000 claims description 6
- 239000002207 metabolite Substances 0.000 claims description 6
- 238000011282 treatment Methods 0.000 claims description 6
- 229930192392 Mitomycin Natural products 0.000 claims description 5
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 claims description 5
- 229940043430 calcium compound Drugs 0.000 claims description 5
- 150000001674 calcium compounds Chemical class 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 229960004857 mitomycin Drugs 0.000 claims description 5
- 239000010902 straw Substances 0.000 claims description 5
- 240000007594 Oryza sativa Species 0.000 claims description 4
- 235000007164 Oryza sativa Nutrition 0.000 claims description 4
- 230000002776 aggregation Effects 0.000 claims description 4
- 238000004220 aggregation Methods 0.000 claims description 4
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 4
- 230000009089 cytolysis Effects 0.000 claims description 4
- 230000034994 death Effects 0.000 claims description 4
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 4
- 238000005374 membrane filtration Methods 0.000 claims description 4
- 150000002972 pentoses Chemical class 0.000 claims description 4
- 235000009566 rice Nutrition 0.000 claims description 4
- 241000209140 Triticum Species 0.000 claims description 3
- 235000021307 Triticum Nutrition 0.000 claims description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 3
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 3
- 229910052742 iron Inorganic materials 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 239000011701 zinc Substances 0.000 claims description 3
- 229910052725 zinc Inorganic materials 0.000 claims description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 2
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 claims description 2
- 229920002527 Glycogen Polymers 0.000 claims description 2
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 claims description 2
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 claims description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 claims description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 2
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 claims description 2
- 229940089837 amygdalin Drugs 0.000 claims description 2
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 claims description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims description 2
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 claims description 2
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 claims description 2
- 229930182830 galactose Natural products 0.000 claims description 2
- 229940096919 glycogen Drugs 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims description 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims description 2
- NGFMICBWJRZIBI-UJPOAAIJSA-N salicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UJPOAAIJSA-N 0.000 claims description 2
- 229940120668 salicin Drugs 0.000 claims description 2
- -1 startch Chemical compound 0.000 claims description 2
- 239000007858 starting material Substances 0.000 claims description 2
- 239000002023 wood Substances 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims 2
- 235000005822 corn Nutrition 0.000 claims 2
- 238000007865 diluting Methods 0.000 claims 2
- 229940050410 gluconate Drugs 0.000 claims 2
- 241000206607 Porphyra umbilicalis Species 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 239000000428 dust Substances 0.000 claims 1
- 230000002452 interceptive effect Effects 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 241
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 83
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 40
- 239000007640 basal medium Substances 0.000 description 30
- 230000004151 fermentation Effects 0.000 description 13
- 238000000855 fermentation Methods 0.000 description 12
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 10
- 229960005091 chloramphenicol Drugs 0.000 description 10
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000013078 crystal Substances 0.000 description 9
- 238000010790 dilution Methods 0.000 description 9
- 239000012895 dilution Substances 0.000 description 9
- 238000011084 recovery Methods 0.000 description 9
- 108010089934 carbohydrase Proteins 0.000 description 7
- 239000002054 inoculum Substances 0.000 description 7
- 230000037353 metabolic pathway Effects 0.000 description 7
- 230000004060 metabolic process Effects 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 6
- 230000037361 pathway Effects 0.000 description 6
- 229910000019 calcium carbonate Inorganic materials 0.000 description 5
- 230000010261 cell growth Effects 0.000 description 5
- 230000001502 supplementing effect Effects 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- PECYZEOJVXMISF-UHFFFAOYSA-N 3-aminoalanine Chemical compound [NH3+]CC(N)C([O-])=O PECYZEOJVXMISF-UHFFFAOYSA-N 0.000 description 4
- 241001112695 Clostridiales Species 0.000 description 4
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 4
- 240000004713 Pisum sativum Species 0.000 description 4
- 235000010582 Pisum sativum Nutrition 0.000 description 4
- 230000002596 correlated effect Effects 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 238000007598 dipping method Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 229920002488 Hemicellulose Polymers 0.000 description 3
- 102000004882 Lipase Human genes 0.000 description 3
- 108090001060 Lipase Proteins 0.000 description 3
- 239000004367 Lipase Substances 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 101710163270 Nuclease Proteins 0.000 description 3
- 102000035195 Peptidases Human genes 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000002053 acidogenic effect Effects 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 238000001030 gas--liquid chromatography Methods 0.000 description 3
- 235000019421 lipase Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000013207 serial dilution Methods 0.000 description 3
- 230000028070 sporulation Effects 0.000 description 3
- 229960003487 xylose Drugs 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108010001478 Bacitracin Proteins 0.000 description 2
- 230000004543 DNA replication Effects 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 108010040201 Polymyxins Proteins 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229960003071 bacitracin Drugs 0.000 description 2
- 229930184125 bacitracin Natural products 0.000 description 2
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000003966 growth inhibitor Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229920005610 lignin Polymers 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000007362 sporulation medium Substances 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 229960000344 thiamine hydrochloride Drugs 0.000 description 2
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 2
- 239000011747 thiamine hydrochloride Substances 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000193446 Thermoanaerobacterium thermosaccharolyticum Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001323 aldoses Chemical class 0.000 description 1
- SRBFZHDQGSBBOR-LECHCGJUSA-N alpha-D-xylose Chemical compound O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-LECHCGJUSA-N 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000004993 binary fission Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 239000004567 concrete Substances 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000001461 cytolytic effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000002635 electroconvulsive therapy Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 239000002816 fuel additive Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000009655 industrial fermentation Methods 0.000 description 1
- 239000004434 industrial solvent Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 239000002029 lignocellulosic biomass Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 230000007524 negative regulation of DNA replication Effects 0.000 description 1
- 230000021616 negative regulation of cell division Effects 0.000 description 1
- 230000017095 negative regulation of cell growth Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000010815 organic waste Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 238000002135 phase contrast microscopy Methods 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229930010796 primary metabolite Natural products 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 239000007166 xylan medium Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/145—Clostridium
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/813—Continuous fermentation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/842—Clostridium
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
OPI DATE 30/12/92 AOJP nATE 111/02/93 APPLN. ID 12422/92 PCT NUMBER PCT/US91/08487 AU9212422 i I t I\INati l i r t l n r, ii i n l b m. REATY (PICT) (51) International Patent Classification 5 International Publication Number: WO 92/20782' C12N 1/36, 1/20, 1/00 A (43) International Publication Date: 26 November 1992 (26.11.92) (21) International Application Number: (22) International Filing Date: 13 1' Priority data: 707,177 24 May I PCT/US91/08487 ovember 1991 (13.11.91) 991 (24.05.91) (71X72) Applicants and Inventors: HSU, Edward, J. [US/US]; 5220 Grand Avenue, Kansas City, MO 64112 (US).
LANDUYT, Sandra, L. [US/US]; 511 North Forest Avenue, Liberty, MO 64068 (US).
(74) Agents: WERESH, John, A. et al.; Hovey, Williams, Timmons Colns. 1101 Walnut Street, Suite 1400, Kansas City, MO 64106 (US).
(81) Designated States: AT, AT(European patent), AU, BB. BE (European patent), BF (OAPI patent). BG, BJ (OAPI patent), BR, CA, CF (OAPI patent), CG (OAPI patent), CH, CH (European patent), CI (OAPI patent), CM (OAPI patent), CS, DE, DE (European patent), DK, DK (European patent), ES, ES (European patent), Fl, FR (European patent), GA (OAPI patent), GB. GB (European patent), GN (OAPI patent), GR (European patent), HU, IT (European patent), JP, KP, KR, LK, LU.
LU (European patent), MC, MG, ML (OAPI patent).- MN, MR (OAPI patent), MW, NL, NL (European patent), NO, PL, RO, SD, SE, SE (European patent), SN (OAPI patent), SU, TD (OAPI patent), TG (OAPI patent).
Published With international search report.
o6i 669a I (54) Title: PROCESS FOR MASSIVE CONVERSION OF CLOSTRIDIA INTO SYNCHRONIZED CELLS OF CRITIC \1 LENGTH OR REFRACTILE ENDOSPORES N
U
0
F
C io 1
E
L
L
M 106 TIME (h) (57) Abstract A method is disclosed lor producing Clostridium which produce solvents, enzymes, antibiotics, toxic proteins or spores, Cell elongation to a critical length of at least about 3X is induced by serial subculturing under controlled conditions to effect synchronization of growth in the number of cells and their effective mass and to rroduce a substantially homogenous cell population. At least about 0,01 M of a divalent cation such as calcium is added to the synchronized cells of critical length to stabilize the cells. Spore formation may be permitted to continue until substantially the entire cell population constitutes refractile mature free spores, which may be harvested.
WO ,'20782 PCT/US91/08487 -1- PROCESS FOR MASSIVE CONVERSION OF CLOSTRIDIA INTO SYNCHRONIZED CELLS OF CRITICAL LENGTH OR REFRACTILE ENDOSPORES Background of the Invention 1. Field of the Invention The present invention relates to a method for synchronizing the growth of clostridia useful in the production of solventogenic cells, enzymes, antibiotics, useful toxic proteins, or refractile endospores. Vegetative cells of bacteria of the genus Clostridium may be massively converted to synchronized solventogenic cells of essentially the same critical length, or the conversion allowed to proceed in a manner such that the production of refractile endospores is selectively induced. More particularly, the bacteria are synchronized in cell number and mass by selective subculturing in a medium containing a slowly metabolizable carbon source to avoid random cell growth. The synchronized cells are elongated to at least three times the length of vegetative cells, at which point they become solventogenic. Synchrony of cell mass and number is stabilized by addition of at least about 0.01M of a divalent cation to the medium. If solventogenesis is to be preserved, growth must be inhibited by chemical or physical means. Where preparation of enzymes, antibiotics or toxic protein producing cells is desired, cell growth may be arrested at selected growth stages beyond the solventogenic stage by inhibition of cell division or DNA replication.
2. Description of the Prior Art Some anaerobic, thermophilic, endospore-forming bacteria of the genus Clostridium are capable of only limited metabolic production of enzymes, antibiotics, toxic proteins, or for producing solvents by acetonebutanol-ethanol (ABE) fermentation. The special capabilities of this genus are largely attributable to their expanded genetic versatility, where significant production of endospores occurs only under a particular physiological condition. Endospores are characterized by their ability to withstand extreme conditions which would destroy the cells in their vegetative state. The morphological changes exhibited by clostridial cells are related to changes in cellular enzyme activity. Depending upon the culture conditions, these bacteria can enter either an acidogenic phase or a solventogenic phase in the WO 92/20782 PCU/US9I/0487 -2process of growth. Regulation of the overall sporulation process is thus a necessary prerequisite to the commercial production of cellular metabolites.
Some species of bacteria of the genus Clostridium are directly capable of converting low cost biomass wastes, such as xylan, or other pentose polymers, into solvents -vithout prior depolymerization of the substrate. By virtue of the fact that certain clostridia are anaerobic and thermophilic, industrial fermentation processes using this genus may be carried out at relatively high temperatures. As a consequence, recovery of their fermentation products requires less energy because it can be accomplished by vacuum distillation directly from the fermentation vessel. Vacuum recovery also reduces the problems associated with solvent toxicity to the fermenting cells. The clostridia have high metabolic rates thus reducing the required residence time in the bioreactor and the ratio of end products to cells is high, maximizing the total bioreactive output. In addition, the use of a thermophilic system along with a simplified culture mediu n and defined and massive numbers of inoculated cells, assures that the system is inherently less subject to contamination. Sterilization of the raw materials therefore may be eliminated.
Lignocellulosic biomass material, the cheapest and most abundant feedstock for bacterial fermentation processes, has three major fractions: crystalline cellulose, hemicellulose, and lignin, each of which must be separately processed. Cellulose can be hydrolyzed to glucose with acid or enzyme catalysts. However, acid catalysts continue to degrade the resulting glucose. Furthermore, enzyme processes are not yet well developed and consequently are not cost efficient. Hemicellulose is largely composed of xylan, which is easily hydrolyzed to xylose but difficult to ferment to ethanol with existing fermentation technologies. Lignin is not a sugar polymer and, therefore, cannot be fermented to produce ethanol but can be thermochemically converted for use as a liquid fuel additive.
Use of anaerobic Clostridium acetobutvlicum for industrial solvent production began at least as early as the 1920's employing a cane molasses feedstock. However, the best solvent yield obtainable was about 1.8% and even this yield was unreliable and unstable due to the susceptibility of C. acetobutvlicum to phage (bacterial virus) infection. The method of the present invention enables control of the rates and yields of product formation WO 12/20782 WO '20782P/US9 1/08487 -3and use of cheaper lignocellulose feedstocks. In especially preferred forms, the present invention utilizes thermophilic organisms of the genus Clostridium which, because of their ability to grow at elevated temperatures, make the process more energy efficient. In addition, thermophilic clostridia are not susceptible to phage infections.
One form of synchronous elongation of Clostridium thermosaccharolticum is described in a chapter by Edward J. Hsu, one of the inventors hereof, in Spore Research published by Academic Press (London, 1976, pp. 223-242), but that description makes no reference to synchronous growth of the cells in the presence of a divalent cation capable of stabilizing the cells during at least final multiplication thereof.
Ethanol-producing mutants of Clostridium thermosaccharo- Ivticum are described in U.S. Patent No. 4,652,526 issued to Edward J. Hsu, one of the inventors hereof. This patent makes no mention of synchronous growth of cells in a growth medium under conditions where a divalent cation is added to stabilize the cells.
Hartmanis, et al. in Applied Microbiology and Biotechnology, Vol. 23 (1986) at pp. 369-371 describe repetitious subculturing of Clostridium acetobutvlicum in a growth medium containing quantities of divalent cations. A small amount of calcium was included in the starter culture to prevent degeneration of the cells after only three transfers. The addition of CaC0 3 permitted as much as ten transfers without degeneration. The calcium addition thus eliminated the need for multiple heat shock treatments for the preparation of a starting culture. However, synchronization of growth in the number of cells and their effective mass is not carried out to produce a substantially homogeneous cell population. The authors describe a process wherein each subculture is allowed to progress for at least about a 24 hour interval to produce heat resistant spores. The minor amount of calcium in the growth medium is said to render the spores more heat-resistant.
U.S. Patent No. 4,778,760 to Ishida, et al. describe the effect of a slight amount of calcium (4 ppm) for stabilizing a thermostable aamylase-producing thermophilic anaerobic bacteria of the Clostridium class.
However, the calcium is not utilized as a component of the growth medium for the bacterial cells.
-4- Summary of the Invention The present invention allows bacteria of the genus Clostridium to be prepared which are useful for selective production of solvents, such as ethanol and butanol at significantly higher levels than heretofore obtainable. In addition, enzymes or antibiotics may be selectively produced. Of equal importance is the fact that whereas previously solvent recoveries have not exceeded about 1 to 2%, this process permits as much as about 11% of the solvent to be recovered.
Butanol and ethanol may be recovered in a ratio of 2:1 at solvent recovery levels of 11%. The ethanol recovery ratio is increased to 1:1 at solvent recovery levels of Advantageously low cost feed stocks may be used as the growth medium for specially prer.red cells. Optionally, the process of cell preparation may be allowed to proceed to full spore formation, all of which is accomplished more efficiently than with past practices.
Accordingly, the present invention provides a process for producing i' 15 bacterial cells useful in s,'lective prod; ction of spores and a metabolic end product selected from the group consisting of solvents, enzymes, antibiotics and useful toxic proteins, and comprising the steps of: providing an initial stock culture containing a carbon source in a growth medium, and at least about 1x10 6 cells per millilitre of bacteria of the genus 20 Clostridium, said bacterial cells, when treated to inhibit division, being genetically capable of metabolizing a carbon source to produce spores or a metabolic end product selected from the group consisting of said solvents, enzymes, antibiotics and proteins; .providing a quantity of a divalent cation source; inducing elongation of said bacterial cells under conditions to produce modified cells of a critical length of at least about 3X while synchronizing the growth in the number of said cells and their effective mass bj' preparing from the initial stock culture another batch subculture which contains a quantty of a slowly metabolizable carbon source other than glucose in a growth medium by adding to the other batch subculture bacterial cells obtained from the initial stock culture and present at a density level no greater than about one half of the density of the bacterial cells present in the initial stock culture; SC CW %IN\N ORD5IMUNM'h PNooW1242C2 DOC -4aincubating said other batch subculture within a time to cause the cells therein to multiply for only about one to one and one half generations in said batch subculture while maintaining the growth medium at a temperature within a range of about -200C to +10 0 C of the species-specific optimum growth temperature, said growth medium being devoid of an amount of cellular metabolites that woutd be sufficient to substantially interfere with synchronous growth of said cells, preparing from an immediately preceding batch subculture a final batch subculture which contains a quantity of a slowly metabolizable carbon source other than glucose in a growth medium by adding to said final batch subculture bacterial cells obtained from the immediately preceding batch subculture and present at a density level no greater than about one half of the density of the bacterial cells present in said immediately preceding batch subculture; S(d) incubating said final batch subculture for a time to cause the cells therein to multiply while maintaining the growth medium at a temperature within the range of step said growth medium being devoid of an amount of cellular metabolites that would be sufficient to substantially interfere with synchronous growth of said i i'' cells, and S(e) carrying out at least incubation step in the presence of at least about 0,01M of said divalent cation and which is sufficient to cause cellular incorporation of an amount of said divalent cation into said elongated cells during step to S.stabilize the cells against death, lysis and aggregation and cause modified cell division in a manner such that, as each cell divides into two cells, the resulting divided cells remain elongated to at least said 3X length, said slowly metabolizable carbon source being selected in each instance to cause the bacteria" *o grow in the selected growth medium at a rate of about 10%-90% less than the maximum growth rate Km for the bacteria in an optimum growth medium; and thereafter selectively subjecting the cells resulting from step to treatment conditions which thereafter inhibit cell division and cause the cells to primarily produce either spores or at least one of said metabolic end products.
SCC DOCINWORfl'SIMONIPdUNtL2j2C -4b- The preferred method hereof broadly includes synchronized growth in the number and mass of substantially anaerobic clostridial cells to a critical length.
The cells aie grown in batch cultures on a low cost carbon source growth medium. The resultant cells of the synchronized culture are at exactly the same stage in the division cycle and the individual cells and their respective processes are said to be "in phase". Depending on the desired end product, the cells may be harvested and stored or the procedure continued with stabilization of the cells by addition of a divalent cation source, followed by inhibition of cell growth. The resultant bacteria are capable of continued metabolism for extended periods of time. Metabolic end products which may be isolated from such cells include solvents, carbohydrate degrading enzymes, proteases, lipases, nucleases, antibiotics, parasporo-like protein crystals, and other toxic proteins as, for example, those which are useful as organic insecticides.
The preferred growth medium is a species-specific basal medium 15 containing about 0.1 to 15.0% on a weight to volume basis of a slowly metabolized carbon source. The growth rate of the bacteria in such medium should be 10-90% less than the maximum growth rate Km for the bacteria in their optimum growth medium. Most preferably, the carbon source may be a pentose polymer such as xylan which may be economically obtained from wheat straw, rice straw, rice hulls, cornstalks, corncobs, fruit peels.
SC C'WINWO 5sM1JLPNOOLL12~22C'f OC WO 92/20782 PCT/US91/08487 hemicellulose and cellulosic residues from paper mill waste or other suitable organic agricultural, industrial, or urban waste.
The cells are synchronized by one or more preferred methods of repeated dilution, centrifugation, or membrane filtration, each followed by repeated subculture. The cells are grown at a temperature of from about 0 C to about +10°C of the species-specific optimum growth temperature.
The growth period is limited to about 1.0 to 1.5 generations, or 1.0 to times the "doubling" time, that is, the time required for a culture to multiply two to three times the initial concentration. At least about three to four discrete growth periods interspersed respectively with two to three dilutions, centrifugations or membrane filtrations to remove cell metabolic wastes are required to synchronize the cells. In preferred embodiments the synchronized cells are all of essentially the same critical length within a range of from at least about 3x and preferably about 4x to about 20x the length of normal vegetative cells. However, the cells may be elongated up to 100x their vegetative length.
The elongated, synchronized cells are subcultured to allow the cells to further multiply from about 1.0 to generations, that is, the time required for the culture to multiply 2 to 4,096 times their prior concentration.
The cells are subcultured in a growth medium containing a divalent cation such as calcium, magnesium, manganese, iron, or zinc to stabilize the activity of the cells and to prevent their death, lysis or aggregation. Good results are obtained by addition of at least about 0.01M of the divalent cation to the growth medium. A quantity of the divalent cation may be utilized which exceeds the solubility thereof in the growth medium, with the excess of the divalent compound dissolving as the divalent cation is incorporated in the cells undergoing multiplication. Better results are obtained if the divalent cation concentration is maintained at a level of from at least about 0,01M to about 0.2M with the preferred concentration of the divalent cation being at least about 0.1M. Three kinds of media may be used: one in which xylan .s the sole carbon source, and the xylan is supplemented with a divalent cation; one in which xylan is supplemented with an additional carbon source that is the divalent salt of an organic acid; and one in which the divalent salt of an organic acid is the sole carbon source. An organic calcium compound such as calcium gluconate, lactate, acetate, butyrate, or formate is preferred.
WO 92/20782 PCT/US91/0b'487 1 -6- Synchronized cells stabilized with calcium gluconate can be sustained, even in the presence of growth inhibitors, for six months. Calcium gluconate is the most preferred divalent cation source because it provides not only the required divalent calcium ion, but also serves as an excellent carbon source which is metabolized in a manner similar to that of glucose but at a much slower rate.
Cultures that are synchronized by sequential transfer (at least two subcultures) in a medium that contains a slowly metabolizable carbon source result in a type of modified cell division not previously reported for any type of bacteria, including the Clostridium species. In accordance with the present invention the cells, for example, elongate 16x to 20x, and form a single septum to divide the cell in an unusual modified manner such that the filament is equally divided into two cells that remain elongated. When septation is observed on the newly formed cells that are 8x to 10x in length, it is either to divide the cell equally once again, or terminally to form a spore septum. Therefore, a cell elongates, for example, to 16x, divides equally to form two cells that are elongated 8x and subsequently divides to form four cells that remain elongated 4x (the critical length).
Suitable sources of a slowly metabolizable carbon source therefor include amygdalin, arabinose, cellobiose, galactose, glycogen, melibiose, a-methylglucoside, B-methylglucoside, raffinose, salicin, starch, trehalose, xylan, Ca-acetate, Ca-butyrate, Ca-citrate, Ca-formate, Cagluconate, and Ca-lactate.
Previous attempts to produce a relatively homogeneous population of free, refractile spores of C. thermosaccharolvticum have been unsuccessful. The method of the present invention includes culture conditions that permit the complete differentiation of vegetative cells to such an extent that virtually 100% free refractile spores may be produced.
Where the desired end product is cells to be sold as a commodity, they may be harvested and washed by repeated centrifugation and resuspension or by filtration and stored at 4°C. On the other hand, if the desired end product is spores, the temperature of the stabilized culture is preferably raised or lowered beyond the culture growth range, -20"C to about 10°C of the optimum temperature for growth. Cell division will cease at that temperature, but cell differentiation, spore formation and metabolism
I
WO 932/210782 PCT/US91/08487 -7will continue. If the desired end product is one that can be produced by elongated, sporulating cells, e.g. solvents, growth of the resulting synchronized, stabilized cells is preferably inhibited by temperature modification, or use of antimicrobial chemical agents such as antibiotics and dyes. Spore formation as well as cell division cease upon such addition but metabolic processes such as solvent production continue.
Brief Description of the Drawings Fig. 1 is a schematic depiction of alternative pathways for production of spores only, spores plus solventogenic cells, or only solventogenic cells; Fig. 2 is a graphic representation of the correlation of synchronous growth, production of solvents, and the utilization of paraffin oil, by a culture incubated in xylan basal medium enriched with calcium gluconate.
(Curves A, B and C, respectively) Fig. 3 is a graphic representation of calcium incorporation by an individual cell in the synchronous culture incubated in xylan basal medium enriched with calcium gluconate; Fig. 4 is a graphic representation of calcium incorporation by an individual cell in the synchronous culture incubated in xylan basal medium enriched with calcium carbonate; and Fig. 5 is a graphic representation of calcium incorporation by an individual cell in the synchronous culture incubated in a calcium gluconate medium.
Description of the Preferred Embodiments As is apparent from the schematic representation of Fig. 1, cells which have been subjected to regulated, synchronized growth that induces elongation may be used selectively to carry out separate metabolic processes identified as pathways I, II and III respectively. When the cells are used in a process represented by pathway I, the elongated cells are solventogenic and solvents may be produced for an extended period of time when cell division is arrested. If cell division is inhibited by physical means such as temperature shift and incubation is allowed to proceed, spore formation commences and WO 92/20782
I
PCr/US91/08487 -8spores ultimately become the predominant product. If growth is inhibited by antimicrobial agents, even under extended incubation times, solvents remain as the predominant product. When the cells are used in a process represented by pathway II, the result is primarily spore production. When the cells are used in a process as indicated by pathway III, principally solvents are produced.
In accordance with a preferred procedure, a basal growth medium #1 is prepared by supplementing a liquid peptone-yeact extract or other medium of conventional composition with a slowly metabolized carbon source. The preferred medium limits growth of the bacteria to at least about less than the maximum growth rate K, in an optimum species-specific growth medium. A preferred growth medium in this respect is a pentose material such as xylan. Sufficient xylan should Le added to provide about of the pentosan on a weight to volume basis.
Xylan, a pentosan compound commonly present in plant cell walls and voody tissue may be obtained by grinding up wheat straw, or any of a number of agricultural, industrial and urban organic waste products. The xylan can be added to the basal medium untreated and in powdered form.
Alternatively, the xylan can be hydrolyzed with hot dilute hydrochloric or other acids to yield xylose, a crystalline aldose sugar commonly called wood sugar, having the general formula CsH 1 00,. Xv lose can also be obtained by coculturing a cellulolytic organism such as C_ thermocellum along with the C. thermosaccharolvticum of the present method on the cellulose basal mediun..
A stock culture is prepared by introducing cells of an exponentially growing culture of the genus Clostridium into a suitable broth medium, such as pea broth. Particularly preferred forms of clostridial bacteria are of the species thermosaccharolvticum American Type Culture Collection Strains (ATCC) #7956, National Canner's Association (NCA), #3814. However species which may be used include perfringens ATCC #13124, thermocellum ATCC #27405, thermohydrosulfuricum ATCC #35045, acetobutvlicum ATCC #824, thermosulfurigenes ATCC #33743, thermoaceticum Dejtsche Sammlung von Mikroorganismen (DSM) #521, thermoautotrophicum DSM #1974, beiierinckii ATCC #25752, and butvricum ATCC #19398.
WO 92/20782 PCT/US91/08487 -9- Synchronization of cell growth may be accomplished by either conventional serial dilution, filtration or centrifugation techniques. Following incubation at the optimum growth temperature and time for a particular clostridial species to reach a cell density of at least about 1 x 106, about one volume of the stock culture is inoculated for each 10 volumes of the xylan basal medium for incubation as a batch culture, identified as basal medium #1 in Fig. 1.
The basal medium #1 containing the Clostridium batch culture is incubated for a time and a temperature which is specific for the preferred species of Clostridium to multiply two to three times the initial concentration or about 1.0 to 1.5 generations.
A basal growth medium #2 is then prepared which is identical in composition to basal medium About one volume of the Clostridium batch culture in medium #1 is transferred to basal medium #2 for each volumes of the basal medium again for incubation as a batch culture.
This culture is similarly maintained at an optimum growth temperature for the species until the culture in medium #2 multiplies two to three times or about 1.0 to 1.5 generations or until the cells reach a concentration of at least about 2-3 x 10 s A growth medium for use in supporting cell metabolisin carried out along one of the metabolic pathways I, or II is prepared by supplementing the xylan basal medium previously described with an organic or inorganic divalent cation source. A growth medium for metabolic pathway III contains a peptone-yeast extract basal medium supplemented with the divalent salt of an organic acid as the sole carbon source. The cation serves to stabilize the cells against death, lysis or aggregation. Preferred divalent cations are magnesium, manganese, iron, zinc, and calcium. Particularly preferred cation sources include organic calcium compounds.
If it is desired to produce both solventogenic cells and spores, metabolic pathway I is used and a preferred stabilization supplement in this respect is calcium gluconate. A growth medium #3 is prepared by supplementing xylan basal medium with at least about 4.3% calcium gluconate on a weight to volume basis (0.1M).
An inoculant of about one volume of the batch culture in basal medium #2 is transferred to growth medium #3 for each 100 volumes of the WO 92/20782 PCT/US91/08487 growth medium. The 1:100 diluted inoculant is incubated as a batch culture for at least about 1 to 12 generations, or 1 to 12 times the "doubling" time or until the cells reach a concentration of about 2 x 1010 or 2 to 4,096 times the initial concentration, at which time the cells demonstrate a high degree of synchrony in both cell mass and cell number. About 90% or more of these cells are elongated a minimum of four times and exhibit a modified cell division such that they remain elongated at a critical length of at least three times and preferably four times their vegetative length. Synchronous, solventogenic cells are harvested at the end of this time, with negligible numbers of spores.
Alternatively, the synchronous, solventogenic cells may be subjected to treatment conditions which would inhibit their growth so that the products of their continued metabolic processes may be harvested. DNA replication and cell division may be inhibited by physical means such as increasing or decreasing the temperature of the cells and growth medium from about +10°C above or -20 0 C below the species-specific optimum growth temperature respectively. In other embodiments,. growth may be inhibited by application of a sublethal dose of an antimicrobial agent. Particularly preferred antimicrobial agents are chloramphenicol, mitomycin, nalidixic acid, and acridine orange.
SIf the goal is solvent production using metabolic pathway I, division of the elongated solventogenic cells is inhibited and solvent production continues during further incubation with negligible concomitant spore production and utilization of paraffin oil as an additional carbon source, As shown in Fig. 2, inhibition of the specially prepared, synchronized cells causes them to enter a stage of increasing solventogenesis. After a given period of time, which varies depending on the species of bacterium selected, solvent production diminishes to a low percentage, indicating continuation of later stages of sporulation.
If incubation is allowed to continue, antibiotics such as polymyxin, bacitracin, carbohydrases such as amylase, proteases, lipases, nucleases, parasporo-like protein crystals, and ultimately, refractile, mature, free spores are produced.
If the desired end product is spores and their related products, then a preferred metabolic pathway is represented by process II of Fig. 1, WO 9'2/20782 PCT/US91/08487 -11wherein a preferred divalent cation supplement is calcium carbonate. A growth medium #4 is prepared by supplementing xylan basal medium with about 1.1% calcium carbonate on a weight to volume basis (0.1M).
An inoculant of about one volume of the batch culture in basal medium #2 is transferred to growth medium #4 for each 100 volumes of the growth medium. The 1:100 diluted inoculant #4 is incubated as a batch culture until the cells again exhibit synchrony in cell mass and number and elongate to at least four times their vegetative length. They exhibit modified cell division such that the daughter cells remain elongated at the critical length. Binary fission of the synchronous cells is inhibited by physical means, such as increasing or decreasing temperature. Continued incubation of this inhibited, synchronized culture results in production of antibiotics, enzymes, parasporo-like crystals, and finally refractile, mature free spores with a low percentage of solvents.
If the desired end product is only solventogenic cells, a preferred metabolic pathway is III of Fig. 1 wherein a medium #5 is prepared for use as a growth medium by supplementing a liquid peptone-yeast extract medium of conventional composition with an organic calcium compound as the sole slowly metabolized carbon source. A preferred organic calcium compound is calcium gluconate present at a level of at least about 4.3% on a weight to volume basis (0.1M).
An inoculant of about one volume of the batch culture in basal medium #2 is transferred to growth medium #5 for each 100 volumes of the growth medium. The 1:100 diluted inoculant #5 is incubated as a batch culture until the cells exhibit synchrony in cell mass and number and elongation to the critical length of about four times their vegetative length with modified cell division. Synchronous, solventogenic cells are harvested at the end of this time, with a low percentage of spores. Where the goal is solvent production using metabolic pathway III, DNA replication and cell division may be inhibited by physical means such as temperature shift, or by use of antimicrobial agents, and the culture is further incubated until solvents are produced, and then continued until solvent production is significantly decreased.
The metabolic products of pathways II and III, may be recovered in accordance with various conventional procedures. For example, WO 92/20782 PCT/US91/0 487 -12if the product is a solvent produced at high temperatures, that is to say, temperatures at or above 50 0 C, recovery may be by vacuum fermentation as described by D.L. Pavia, et al., Introduction to Organic Laboratory Techniques, A Contemporary Approach, at 548-552, B. Saunders, 1976), and Cysewski and Wilke, "Rapid Ethanol Fermentation Using Vacuum and Cell Recycle", Vol. XIX Biotechnology and Engineering, 1125-1143, 1977. If the product is a solvent produced at temperatures below 50°C, the product may be recovered by standard distillation processes. Enzymes, such as carbohydrases are extracellular products which are recovered by removing cellular debris by filtration or centrifugation. If further purification of enzymes from crude extract is desired, recovery may be as described by D. I. C. Wang, et al., Fermentation and Enzyme Technology, at 238-310, (John Wiley Sons, 1979). Parasporo-like protein crystals and useful toxic proteins are contained within the spores and may be harvested by repeated centrifugation or filtration. The cells are centrifuged or filtered, resuspended, again centrifuged or filtered, resuspended, and again centrifuged or filtered. Pure, dry spores are then recovered. If the product is antibiotics, recovery is by conventional extraction with a solvent such as propanol or butyl acetate as described by Crueger and Crueger in biotechnology: A Textbook of Industrial MicrobioloRv, at 99-103, (Sinauer, Science Tech, 1982).
Growth medium #5 may be substituted in the above described procedures for xylan basal medium #1 and In other respects the procedures remain the same including the final 1:100 dilution into growth medium The dilute inoculant is incubated as a batch culture until the cells exhibit elongation, synchrony and modified cell division as previously described. Synchronous, solventogenic cells are harvested at the end of this time, with negligible numbers of spores.
As another alternative procedure, growth of the synchronous, solventogenic cells may be inhibited to channel the energy of the. cells into metabolism rather than cell division and to permit harvesting of the products of their continued metabolic processes. The temperature of the cells and growth medium may be increased to about 10 0 C above or decreased to about 206C below the species-specific optimum growth temperature respectively, or a sublethal dose of an antimicrobial agent may be administered. The growthinhibited culture is further incubated and solvents are produced with WO 92/20782 PCT/US91/08487 -13negligible concomitant spore production. After a given period of time which varies depending on the bacterial species, the percentage of solvents produced varies as, for example from 6% to as high as about 12% and the butanol:ethanol ratio varies as, for example 1:1 to 2:1.
In other embodiments, the step of subculturing in a second basal medium is repeated and the initial dilution into fresh medium is repeated prior to transfer into a third growth medium. The initial dilution into fresh basal medium may be from about 1:2 to 1:100, which may be repeated, and the final dilution may be from about 1:2 to 1:500. Repeated centrifugation or membrane filtration and resuspension may be substituted for serial dilution as a method for synchronization of the cultures.
In all embodiments tested, in order to maintain solventogenesis for extended periods, the elongated, synchronous cells appeared to require a carbon source that is slowly metabolized; normal cell division must be stopped by a temperature shift or the addition of chemical growth inhibitors; and the cells must incorporate calcium. Figs. 3-5 compare calcium incorporation of individual synchronized Clostridium thermosaccharolvticum cells to the calcium incorporation of the typical asynchronous, short, vegetative cells, As illustrated by Curves A1-A4 in each of the Figures, it can be seen that incorporation of calcium stabilized the solventogenic cells and protected them from the high concentrations of solvents that were subsequently produced.
Conversely, the Curve B cells of each Figure that were not synchronized prior to the addition of excess calcium, remained as typical, short, vegetative cells, that did not incorporate high concentrations of calcium and were predominantly acidogenic. However, even in these acidogenic cells, when cell division was stopped at 45 hours by shifting to 35 0 C, the cells elongated, produced solvents, and there was an increase in calcium incorporation.
Example I This example sets forth the preferred procedures for synchronizing the growth of cell number and mass and altering cell division in cultures of wild type Clostridium thermosaccharolvticum, (ATCC) #7956.
WO 92/20782 PCT/US91/08487 -14- Pea Broth Six dried Alaskan seed peas in 10 ml of 2% peptone solution, autoclaved for 15 minutes, immediately overlayed with 2 ml c f sterile vaspar.
Stock Cultures Inoculation of pea broth with an exponentially growing culture of C.
thermosaccharolvticum, followed by incubation for 8 hours at 56 0 C. The stock culture was then stored at 4 0 C. Stock cultures were transferred at 3-6 month intervals. Stock cultures were activated by incubation for 12 hours at 56 0
C.
Batch Cultures One ml of activated culture was transferred to 10 ml of fresh basal medium for use as a batch culture.
Basal Medium 0.2% peptone yeast extract 0.01%/ CaC12,2H 2 0 0.1% (NH 2 4
SO
4 0.01% MgSO 4 0.01% MnSO 4
H
2 0O 0.0005% ZnSO 4 -7H 2 0 0.0005% CuSO 4 '5H 2 0 0.0001% (NH 4 6 Mo 7
O
24 4HO 0.00005% FeSO 4 '7HO 2 0.000002% p-aminobenzoic acid 0.0001% thiamine hydrochloride 0.0000001% biotin in one liter of water. The thiamine hydrochloride and biotin were filtered, sterilized, and added to the medium after autoclaving. 0.5% (w/v) xylan was added as a carbon source. Media pH was adjusted to 7.0 with 1M NaOH and then sterilized. The medium was preincubated to 56CC and used within one day.
WO 92/20782 PCT/US91/08487 Procedure All procedures were performed under anaerobic conditions using the Hungate procedure. A stock culture was activated, transferred to preincubated basal medium containing 0.5% xylan as a carbon source, and incubated at 56 0 C for 6 hours, at which time the cell density was approximately 3 x 10 8 cells/ml. A 1 ml aliquot of the culture was aseptically transferred to 10 ml of fresh, preincubated xylan basal medium and again allowed to grow as a batch culture at 56 0 C. After four hours, the culture reached a cell density of approximately 1 x 108 cells/ml. A 1 ml aliquot of the culture was aseptically transferred to 100 ml of fresh, preincubated xylan basal medium which had been supplemented with at least about 4.3% (0.1M) calcium gluconate. The culture was maintained in a serial dilution bottle and overlayed with 40 ml of sterile paraffin oil to ensure maintenance of anaerobic conditions. The culture was incubated in a rotary water bath shaker at 56°C and 150 rpm.
After 45 hours, the culture reached a cell density of approximately 2 x 109 cells/ml.
These solventogenic cells were harvested by centrifugation at 22,000 x g for 30 minutes, resuspended in sterile distilled water, centrifuged at 22,000 x g for 30 minutes, resuspended in sterile distilled water, centrifuged at 22,000 x g for 30 minutes, at which point the cells were ready for immobilization and storage at 4°C.
The cells were differentially counted under a microscope using a Petroff Hausser counting chambr to determine the total number of cells, length of individual cells, number of sporangia, and number of refractile spores. An Olympus phase contrast microscope with a magnification of 400x was used. The morphology was ccnfirmed at 1,000x.
The culture supernatant fluid was analyzed by gas-liquid chromatography (GLC) using a Hewlett-Packard GLC, Model 5700, equipped with a flame ionization detector and strip-chart recorder. Primary metabolites were separated on a stainless steel column (0.31 cm by 1.82 m) packed with 100/120 Chromosorb W AW coated with 10% SP-lu00/1% H 3
PO
4 (Supelco, Inc.,) The column was conditioned for 48 hours at 2000C. For analysis the injection port temperature was 200 0 C and the detector temperature was 250 0 C. Prepurified nitrogen was used as the carrier gas with a flow rate of 40 ml/min. Hydrogen and compressed air flow rates were 30 and 300 WO 92/20782 PCT/US91/08487 -16ml/min, respectively. The electrometer range was set at 10' A/mv with an attenuation of 16 and a range of 10. The oven temperature was held at 80 0
C
for 2 minutes after injection of the 10 microliter sample, then programmed to 170 0 C at a range of 8 0 C/min, followed by a 2 minute hold period.
Metabolite percentages were calculated from the area of standard reference peaks and converted to millimolar concentrations.
Samples obtained for counting and GLC analysis were subsequently centrifuged at 2200 x g for 30 minutes to separate the cells from the culture medium. The cells were resuspended in sterile distilled water and the procedure 2peated three times, following which the pellet was resuspended in 5 ml of sterile distilled water and sonicated to 90% disruption, as confirmed by phase-contrast microscopy. A model 400 Dionex ion chromatograph equipped with a Hewlett-Packard 9000 computer and autosampler was used for ion chromatographic analysis. Cations were separated on a CS-1 column. The eluent for sodium, ammonium, and potassium was 8 mM HCI plus 1 mM 2,3-diaminopropionic acid at ml/n'dn. The eluent for magnesium, manganese,.and calcium was 48 mM HCI plus 8 mM 2,3-diaminopropionic acid at a flow rate of 0.8 ml min' 1 Anions were separated on an AS4A column using an eluent of 1.92 mM sodium carbonate plus 2.4 mM sodium bicarbonate at 2.0 ml/min.
Results Cultures synchronized by repeated transfer in xylan medium within 6 hours and subsequently grown for 45 hours in the presence of xylan enriched with excess calcium gluconate demonstrated a high degree of synchrony both in cell mass and cell number. Differential count of the cells revealed 69.3% synchrony in cell mass and 76.7% synchrony in cell number.
More the 90% of these synchronous, solventogenic cells elongated a minimum of four times and exhibited a modified cell division such that they remained elongated at a critical length of at least four times vegetative length. The number of refractile spores was negligible.
Example II WO 92/20782 PCI'/US91/08487 -17- The procedure of Example I was repeated except that the first incubation of a 1:10 dilution of the stock culture was followed by a second incubation of a 1:10 dilution of the culture in fresh, preincubated xylan basal medium. This dilution was again allowed to grow as a batch culture at 56 0
C.
After 4 hours, the culture reached a cell density of approximately 1 x 108, and the remainder of the procedure of Example I was completed. More than of these synchronous cells elongated a minimum of four times and exhibited a modified cell division such that they remained elongated at a critical length of at least four times vegetative length. The number of refractile spores was negligible.
Example III The procedure of Example I was repeated except that after 45 hours the temperature was lowered to 35 0 C by dipping the culture in an ice bath and transferring it to a rotary incubator at 35 0 C. The culture was incubated for an additional 135 hours (180 hours total incubation time) at 35"C. After 180 hours the culture reached a cell density of approximately 2 x 109 cells/ml. Cells prepared in this manner produced 10.6% solvents with a butanol:ethanol ratio of 2:1.
Correlation of synchrony in cell number and corresponding concentration of solvents it shown in Fig. 5. Curve A shows the total cell count, with the degree of synchrony shown parenthetically as a percentage.
Curve B shows the absolute concentration of solvents produced, with alcohol shown parenthetically on a volume/volume basis. The total millimolar solvent concentration is equal to the sum of the concentrations of the individual solvents: acetone, butanol, ethanol, isopropanol, and methanol.
Although solvents were produced from the beginning of the fermentation, the total millimolar concentrations, shown in Curve B, were relatively low during the synchronous growth period shown in Curve A.
When the temperature was shifted to 35 0 C after 45 hours of incubation, the arrested, elongaterd cells entered a stage of increasing solventogenesis such that at 115 hours the total concentration was at 130 hours the concentration increased to and at 145 hours the concentration further increased to The highest concentration of solvents, 10.6%, was observed at 175 hours.
1"i, 921120782 PC'/US91/08j87 -18- Example IV The procedure of Example III was repeated except that following the reduction in temperature the culture was incubated for an additional 155 hours (200 hours total incubation time) at 35 0 C. After 200 hours the culture reached a cell d :nsity of approximately 2 x 10 9 cells/ml.
Cells prepared in this manner produced 6.5% solvents with a butanol:ethanol ratio of 1:1.
Example V The procedure of Example II was repeated except that following the reduction in temperature the culture was incubated for an additional 200 hours (245 hours total incubation time) at 35 0 C. After 245 hours the culture reached a cell density of approximately 2 x 109 cells/ml, Cells prepared in this manner produced significant amounts of antibiotics, such as polymyxin, bacitracin, carbohydrases such as amylase, proteases, lipases, nucleases; parasporo-like protein crystals, and refractile, mature, free spores.
Example VI The procedure of Example I was repeated except that after hours the temperature was increased to 70'C by transferring the culture to a rotary incubator at 70 0 C. The culture was incubated an additional 135 hours (180 hours total incubation time) at 70'C. After 180 hours the culture reached a cell density of approximately 2 x 10' cells/ml. Cells prepared in this manner produced 10.6% solvents with a butanol:ethanol ratio of 2:1.
Example VII The procedure of Example VI was repeated except that after increasing the temperature to 70°C the culture was incubated an additional 155 hours (200 hours total incubation time) at 70°C. After 200 hours the culture reached a cell density of approximately 2 x 1 0 9 cells/ml. Cells prepared in this manner produced 6.5% solvents with a butanol:ethanol ratio of 1:1.
Example VIII WO 92/20782 WPCI/US91/08487 -19- The procedure of Example VI was repeated except that after shifting the temperature to 70 0 C the culture was incubated an additional 200 hours (245 hours total incubation time) at 70 0 C, After 245 hours the culture reached a cell density of approximately 2 x 109 cells/ml. Cells prepared in this manner produced antibiotics, carbohydrases, parasporo-like protein crystals, and refractile, mature, free spores.
Example IX The procedure of Example I was repeated except that after hours chloramphenicol was added to give a 20 micromolar final concentration in order to prev'nt further cell division. The culture was incubated for an additional 27 hours (72 hours total incubation time). After 27 hours the culture reached a cell density of approximately 2 x 109 cells/ml. Cells prepared in this manner produced 10.6% solvents with a butanol:ethanol ratio of 2:1 Example X The procedure of Example IX was repeated except that after addition of chloramphenicol the culture was incubated an additional 42 hours (87 hours total incubation time). After 87 hours the culture reached a cell density of approximately 2 x 109 cells/ml. Cells prepared in this manner produced 6.5% solvents with a butanol:ethanol ratio of 1:1.
Calcium incorporation by an individual cell in the synchronous culture incubated in xylan basal medium enriched with calcium gluconate is shown in Fig. 3. The highest solvent production correlated with the highest calcium incorporation as shown in Curves A1-A4. Cell division was stopped at 45 hours by addition of chloramphenicol in Curve Al, nalidixic acid in Curve A2, mitomycin in Curve A3, and acridine orange in Curve A4. The cells treated with nalidixic acid of Curve A2 produced 7.1% solvents at 72 hours, which correlated with the highest incorporation of calcium, 3,162 nanomoles. When acridine orange was added to the synchronized cells in the same medium, shown in Curve A4, the solvent concentration reached 8.1 0 with calcium incorporation of 1,163 nanomoles. Curve B represents the calcium incorporation by an individual cell in an asynchronous culture incubated in the same medium, WO 92/20782 PCT/US91/08487 Example XI The procedure of Example I was repeated except that a sporulation medium of xylan with 1.1% (0.1M) calcium carbonate was used. After hours the cells exhibited a high degree of synchrony both in mass and number. Differential count of the cells revealed 48.8% synchrony in cell mass and 56.3% synchrony in cell number. More than 90% of these synchronous, solventogenic cells elongated a minimum of four times and exhibited a modified cell division such that they remained elongated at a critical length of at least four times vegetative length. The number of refractile, mature free spores was negligible.
Example XII The procedure of Example XI was repeated except that after hours, the temperature was lowered to 35 0 C by dipping the culture in an ice bath and transferring it to a rotary incubator at 35 0 C. The culture was incubated for an additional 200 hours (245 hours total incubation time) at 0 C. After 245 hours the culture reached a density of approximately 2 x 10 9 cells/ml. Cells prepared in this manner produced antibiotics, carbohydrases, parasporo-like protein crystals, and refractile, mature, free spores.
Example XIII The procedure of Example XII was repeated except that after hours, the temperature was increased to 70CC by transferring the culture to a rotary incubator at 70'C. The culture was incubated for an additional 200 hours (245 hours total incubation time) at 70C. After 245 hours, the culture reached a density of approximately 2 x 109 cells/ml. Cells prepared in this manner produced antibiotics, carbohydrases, parasporo-like protein crystals, and refractile, mature, free spores.
Example XIV The procedure of Example XI was repeated except that after hours nalidixic acid was added to give a 20 micromolar final concentration in order to prevent further cell division. The culture was incubated for an WG 92/20782 W7crUS9 I/0848 7 -21additional 27 hours (72 hours total incubation time). After 27 hours, the culture reached a cell density of approximately 2 x 109 cells/ml. Cells prepared in this manner produce negligible solvents and may produce antibiotics, carbohydrases, parasporo-like protein crystals, and refractile, mature, free spores.
Calcium incorporation by an individual cell in the synchronous culture incubated in xylan basal medium enriched with calcium carbonate is shown in Fig. 4. Although these cells did not produce high concentrations of solvents, the highest solvent production correlated with the highest calcium incorporation as shown in Curves A1-A4. Cell division was stopped at 45 hours by addition of chloramphenicol in Curve Al, nalidixic acid in Curve A2, mitomycin in Curve A3, and acridine orange in Curve A4.
The synchronous cells inhibited with nalidixic acid of Curve A2 incorporated 12,492 nanomoles of calcium at 72 hours and 40-50% of the cells showed signs of terminal swelling indicative of Stage IV to V of sporulation. In contrast, synchronous cells in the same medium inhibited with acridine orange of Curve A4 incorporated 754 nanomoles of calcium and produced 0.4% solvents. Curve B represents the calcium incorporation by an individual cell in the asynchronous culture incubated in the same medium.
Example XV The procedure of Example I was repeated except that a sporulation medium with at least 4.3% calcium gluconate as the sole carbon source was used. After 45 hours the culture reached a density of approximately 2 x 10 9 cells/ml. Cells prepared in this manner were highly elongated and solventogenic. Refractile, mature, free spores or refractile sporangia were not produced in significant amounts.
Example XVI The procedure of Example XV was repeated except that after hours the temperature was lowered to 35 0 C by dipping the culture in an ice bath and transferring it to a rotary incubator at 35'C. The culture was incubated for 135 hours (180 hours total incubation time) at 35 0 C. After 180 hours the culture reached a density of approximately 2 x 109 cells/ml. Cells WO 92/20782 PCT/US91/08487 -22prepared in this manner produced 10.6% solvents with a butanol:ethanol ratio of 2:1.
Example XVII The procedure of Example XV was repeated except that after temperature reduction the cells are incubated an additional 155 hours (195 hours total incubation time). After 195 hours the culture reached a density of approximately 2 x 109 cells/ml. Cells prepared in this manner produced solvents with a butanol:ethanol ratio of 1:1.
Example XVIII The procedure of Example XV was repeated except that after hours the temperature was increased to 70°C by transferring the culture to a rotary incubator at 70 0 C. The culture was incubated an additional 135 hours (180 hours total incubation time) at 35 0 C. After 180 hours the culture reached a density of approximately 2 x 10 9 cells/ml. Cells prepared in this manner produced 10.6% solvents with a b:.anol:ethanol ratio of 2:1.
Example XIX The procedure of Example XVIII was repeated except that after increasing the temperature the culture was incubated an additional 155 hours (195 hours total incubation time) at 70'C. After 105 hours the culturc reached a density of approximately 2 x 109 cells/mi. Cells prepared in this manner produced 6.5% solvents with a butanol:ethanol ratio of 1:1.
Example XX The procedure of Example XV was repeated except that after hours chloramphenicol was added to give a 20 micromolar final concentration in order to prevent further cell division. The culture was incubated for an addit;onal 27 hours (72 hours total incubation time). After 27 hours the culture reached a cell density of approximately 2 x 10 9 cells/mL, Cells prepared in this manner produced 10.6% solvents with a butanol:ethanol ratio of 2:1.
Example XXI WO 92/20782 PCT/US91/08487 -23- The procedure of Example XV was repeated except that after the addition of chloramphenicol the culture was incubated an additional 42 hours (87 hours total incubation time). After 87 hours the culture reached a cell density of approximately 2 x 109 cells/ml. Cells prepared in this manner produced 6.5% solvents ,with a butanol:ethanol ratio of 1:1.
Calcium incorporation by an individual cell in the synchronous culture incubated in calcium gluconate medium is shown in Fig. 5. The correlation between the peak in solventogenesis and calcium incorporation is showr in Curves A1-A4. Cell division was stopped at 26 hours by addition of chloramphenicol in Curve Al, nalidixic acid in Curve A2, mitomycin in Curve A3, and acridine orange in Curve A4. The synchronous cells treated with nalidixic acid of Curve A2 produced 9.1% solvents at 72 hours, which correlated with the incorporation of 1,940 nanomoles of calcium. Curve B represents the calcium incorporation by an individual cell in the asynchronous culture incubated in the same medium.
Example XXII The procedure of Example I was repeated except that the basal medium contained at least 4.3% calcium gluconate as the sole carbon source was used. After 26 hours the culture reached a density of approximately 2 x 109 cells/ml. Cells prepared in this manner were highly elongated and solventogenic. Refractile, mature, free spores or refractile sporangia were not produced in significant amounts.
Example XXIII The procedure of Example XII was repeated except that after 26 hours the temperature was lowered to 35°C by dipping the culture in an ice bath and transferring it to a rotary incubator at 35'C. The culture was incubated for 135 hours (180 hours total incubation time) at 35 0 C. After 180 hours the culture reached a density of approximately 2 x 109 cells/ml. Cells prepared in this manner produced 10.6% solvents with a butanol:ethanol ratio of 2:1.
Example XXIV WO 9212072, PCT/US91/08487 -24- The procedure of Example XXII was repeated except that after temperature reduction the cells are incubated an additional 155 hours (195 hours total incubation time). After 195 hours the culture reached a density of approximately 2 x 109 cells/ml. Cells prepared in this manner produced 6.5% solvents with a butanol:ethanol ratio of 1:1.
Example XXV The procedure of Example XXII was repeated except that after 26 hours the temperature was increased to 70 0 C by transferring the culture to a rotary incubator at 70 0 C. The culture was incubated an additional 135 hours (180 hours total incubation time) at 35°C. After 180 hours the culture reached a density of approximately 2 x 109 cells/ml. Cells prepared in this manner produced 10.6% solvents with a butanol:ethanol ratio of 2:1.
Example XXVI The procedure of Example XXV was repeated except that after increasing the temperature the culture was incubated an additional 155 hours (195 hours total incubation time) at 70 0 C. After 195 hours the culture reached a density of approximately 2 x 109 cells/ml. Cells prepared in this manner produced 6.5% solvents with a buzanol:ethanol ratio of 1:1.
Example XXVII The procedure of Example XXII was repeated except that after 26 hours chloramphenicol was added to give a 20 micromolar final concentration in order to prevent further cell division. The culture was incubated for an additional 27 hours (72 hours total incubation time). After 27 hours the culture reached a cell densi-y of approximately 2 x 10 9 cells/ml. Cells prepared in this manner produced 10.6% solvents with a butanol:ethanol ratio of 2:1.
Example XXVIII The procedure of Example XXII was repeated except that after the addition of chloramphenicol the culture was incubated an additional 42 hours (87 hours total incubation time). After 87 hours the culture reached WO 92/20782 PCT/US91/08487 a cell density of approximately 2 x 109 cells/ml. Cells prepared in this manner produced 6.5% solvents with a butanol:ethanol ratio of 1:1.
The use of an oleaginous material as an overlay for the growth medium during cell multiplication serves the dual function of maintaining an anaerobic environment for growth of the cells and at the same time providing a secondary carbon source. A saturated hydrocarbon such as paraffin oil is the preferred oleaginous agent, primarily because of its availability at a reasonable cost. Furthermore, the use of paraffin oil as an overlay for the growth medium allows a standard vessel to be used for fermentation and thereby avoiding the necessity of employing expensive fermentation equipment which usually incorporate cooling apparatus, aeration and agitation means. In the present process, slow mechanical mixing of the growth medium is adequrte under conditions that do not interfere with the oxygen-excluding, coherent characteristics of the oleaginous layer. An open top concrete, metal or wood vessel is suitable in this respect, thus permitting the utilization of existing structures.
In like manner, in view of the fact that the only external energy required is to increase the temperature of the growth medium to a required level, about 56 0 C in the case of C. thermosaccharolyticum, thermal energy obtained from solar power will in many instances be adequate, particularly if the growth medium is introduced into a metal walled vessel exposed to the sun. In the case where the carbon source is the spent liquor from a pulp mill, that liquor is generally available out of the plant at a temperature of at least about 90"C and therefore need only to be allowed to cool- to the desired level before initiation of the fermentation processes described herein.
Claims (18)
1. A process for producing bacterial cells useful in selective production of spores and a metabolic end product selected from the group consisting of solvents, enzymes, antibiotics and useful toxic proteins, and including the steps of: providing an initial stock culture containing a carbon source in a growth medium, and at least about 1x10 6 cells per millilitre of bacteria of the genus Clostridium, said bacterial cells, when treated to inhibit division, being genetically capable of metabolizing a carbon source to produce spores or a metabolic end product selected from the group consisting of said solvents, enzymes, antibiotics and proteins; providing a quantity of a divalent cation source; inducing elongation of said bacterial cells under conditions to produce modified cells of a critical length of at least about 3X while synchronizing the S* 15 growth in the number of said cells and their effective mass by preparing from the initial stock culture another batch subculture which i contains a quantity of a slowly metabolizable carbon source other than glucose in a growth medium by adding to the other batch subculture bacterial cells obtained ;0 from the initial stock culture and present at a density level no greater than about 20 one half of the density of the bacterial cells present in the initial stock culture; incubating said other batch subculture within a time to cause the cells therein to multiply for only about one to one and one half generations in said batch subculture while maintaining the growth medium at a temperature within a :i *range of about -20°C to +10°C of the species-specific optimum growth temoerature, said growth medium being devoid of an amount of cellular metabolites that would be sufficient to substantially interfere with synchronous growth of said cells, preparing from an immediately preceding batch subculture a final batch subculture which contains a quantity of a slowly metabolizable carbon source other than glucose in a growth medium by adding to said final batch subculture bacterial cells obtained from the immediately preceding batch subculture and SC C :WINVObSIMO~FO NttLi2Jflt 4 .XX -27- present at a density level no greater than about one half of the density of the bacterial cells present in said immediately preceding batch subculture; incubating said final batch subculture for a time to cause the cells therein to multiply while maintaining the growth medium at a temperature within the range of step said growth medium being devoid of an amount of uellular metabolites that would be sufficient to substantially interfere with synchronous growth of said cells, and carrying out at least incubation step in the presence of at least about 0.01M of said divalent cation and which is sufficient to cause cellular incorporation of an amount of said divalent cation into said elongated cells during step to stabilize the cells against death, lysis and aggregation and cause modified cell division in a manner such that, as each cell divides into two cells, the resulting divided cells remain elongated to at least said 3X length, said slowly metabolizable carbon source being selected in each instance to cause the bacteria to grow in the selected growth medium at a rate of about 10%-90% less than the maximum growth rate Km for the bacteria in an optimum growth medium; and thereafter selectively subjecting 'he cells resulting from step to treatment conditions which thereafter inhibit cell division and cause the cells to primarily produce either spores or at least one of said nmetabolic end products.
2. A process according to claim 1, wherein step includes providing said divalent cation at a concentration of at least about 0.01 M to about 0.2M.
3. A process according to claim 1 or claim 2 wherein the step of subjecting the cells resulting from step to treatment conditions which inhibit cell division includes adding an antimicrobial agent selected from the group consisting of chloramphenenicol, mitomycin, nalidixic acid, and acridine orange,
4. A process according to any one of claims I to 3 wherein the step of subjecting the cells from step to treatment conditions which inhibit cell division includes reducing the temperature of said cells below the range specified in step A process according to any one of claims 1 to 3 wherein the step of subjecting the cells resulting from step to treatment conditions which inhibit SC \WINWORWIMONErtPNODEL' W 22C I DOC -28- cell division includes increasing the temperature of said cells above the range specified in step
6. A process according to any one of claims 1 to 5 wherein the growth medium includes a substantial proportion of a pentose polymer.
7. A process according to any one of claims 1 to 6 wherein the growth medium includes a substantial proportion of a slowly metabolizable carbon source selected from the group consisting of amygdalin, arabinose, cellobiose, galactose, glycogen, melibiose, ac-methylglucoside, p-methylglucoside, raffinose, salicin, startch, trehalose, xylan, Ca-acetate, Ca-butyrate, Ca-citrate, Ca-formate, Ca-gluconate, and Ca-lactate.
8. A process according to any one of claims 1 to 7 wherein the growth medium is a medium containing a substantial proportion of a starting material selected from the group consisting of wheat straw, rice straw, rice hulls, corn stalks and corn ccbs, saw dust, wood chips, cellulose and hemicellulosic residues.
9. A process according to any one of claims 1 to 8 wherein said divat cation source contains cations selected from the group consisting of magnesiu. manganese, iron, zinc and calcium. A process according to any one of claims 1 to 9 wherein said divalent cation source contains an organic calcium compound selected from the group consisting of Ca-gluconate, Ca-lactate, Ca-acetate, Ca-butyrate, Ca-formate, Ca- carbonate and Ca-sulfate.
11. A process according to claim 10 wherein is included the step of mechanically agitating the growth medium without interfering with the oxygen 25 excluding integrity of the oleaginous laver thereover during multiplication of the cells in the growth medium.
12. A process according to any one of claims 1 to 11 wherein said modified cell elongation and synchronization of growth in the number of said cells and their effective mass is accomplished by: carrying out at least one additional subculture end incubation step between steps and of claim 1 wherein in each instance a batch subculture is Sprepared which contains a quantity of said slowly metabolizable carbon source in t itlNtX)ttS'TSlir II PXO -29- a growth medium and bacterial cells obtained from the immediately preceding batch subculture at a density level no greater than about one half of the density of the bacterial cells present in the immediately preceding batch subculture, and the batch subculture thus prepared incubated for a time to cause the cells therein to multiply only about one to one and one half generations.
13. A process according to any one of claims 1 to 12 wherein each batch subculture and the final subculture are prepared by removing an aliquot of the growth medium containing said cells from the initial stock culture and a preceding batch subculture respectively and diluting each aliquot from about 1:2 to about 1:100 with a fresh quantity of a growth medium which contains a quantity of said slowly metabolizable carbon source.
14. A process according to any one of claims 1 to 12 wherein each batch subculture is prepared by removing an aliquot of the growth medium containing said cells from the initial stock culture and a preceding batch subculture respectively and diluting each aliquot from about 1:2 to about 1:500 with a fresh quantity of a growth medium which contains a quantity of said slowly metabolizable carbon source. A process according to any one of claims 1 to 14 wherein the step of adding said cells to corresponding subcultures includes the steps of separating the cells from said stock culture and a preceding subculture respectively by centrifugation. 16, A process according to any one of claims 1 to 15 wherein the step of adding said cells to corresponding subcultures includes the step of separating the cells from said stock culture and a preceding subculture respectively by 25 membrane filtration,
17. A process according to any one of claims 1 to 16 wherein said subculturing and incubation steps are all carried out under anaerobic conditions and including S"the step of maintaining a layer of ar, oleaginous material over the growth medium to serve as a secondary carbon source.
18. A process according to claim 17, wherein said oleaginous material is a paraffin oil, DGC ,V|NDOWS'1t ,I 12412029 DOW
19. A process according to any one of claims 1 to 18 wherein said slowly metabolizable carbon source in steps and is the divalent cation source. A process according to claim 21, wherein said source is calcium gluconate.
21. A spore or metabolic product made in accordance with a process according to any one of claims 1 to
22. A spore or metabolic end product in accordance with the process of any one of claims 1 to
23. A process for producing bacterial cells substantially as hereinbefore described with reference to the examples. DATED: 10 November, 1995 PHILLIPS, ORMONDE FITZPATRICK Attorneys for: ED\NARD J. HSU A9t i
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/707,177 US5158887A (en) | 1990-09-09 | 1991-05-24 | Process for massive conversion of clostridia in synchronized cells of elongated length or refractile endospores |
| US707177 | 1991-05-24 | ||
| PCT/US1991/008487 WO1992020782A1 (en) | 1991-05-24 | 1991-11-13 | Process for massive conversion of clostridia into synchronized cells of critical length or refractile endospores |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU1242292A AU1242292A (en) | 1992-12-30 |
| AU669477B2 true AU669477B2 (en) | 1996-06-13 |
Family
ID=24840664
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU12422/92A Ceased AU669477B2 (en) | 1991-05-24 | 1991-11-13 | Process for massive conversion of clostridia into synchronized cells of critical length or refractile endospores |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5158887A (en) |
| EP (1) | EP0587566A4 (en) |
| JP (1) | JPH04356186A (en) |
| AU (1) | AU669477B2 (en) |
| BR (1) | BR9107308A (en) |
| CA (1) | CA2109808A1 (en) |
| RU (1) | RU2091483C1 (en) |
| WO (1) | WO1992020782A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2692266C (en) * | 2007-09-27 | 2019-04-16 | Ls9, Inc. | Reduction of the toxic effect of impurities from raw materials by extractive fermentation |
| EP2308992A4 (en) * | 2008-03-17 | 2011-07-13 | Tsuji Takashi | Screening method for efficiently obtaining useful microbial strains from microbial sample obtained from natural environment and reagent and screening kit to be used therefor |
| RU2381270C1 (en) * | 2008-08-28 | 2010-02-10 | Открытое акционерное общество "Корпорация Биотехнологии" | STRAIN OF BACTERIA Clostridium acetobutylicum-PRODUCER OF BUTANOL, ACETONE AND ETHANOL |
| RU2404247C2 (en) * | 2008-08-28 | 2010-11-20 | Открытое акционерное общество "Корпорация Биотехнологии" | Method of obtaining butanol |
| RU2393213C1 (en) * | 2008-12-17 | 2010-06-27 | Государственное научное учреждение "Всероссийский научно-исследовательский институт пищевой биотехнологии Российской академии сельскохозяйственных наук" | Clostridium acetobutylicum bacteria strain - producer of n-butyl alcohol, acetone and ethanol |
| MX349265B (en) | 2010-05-20 | 2017-07-20 | Ecolab Usa Inc | Rheology modified low foaming liquid antimicrobial compositions and methods of use thereof. |
| RU2509151C1 (en) * | 2012-11-09 | 2014-03-10 | Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт генетики и селекции промышленных микроорганизмов" (ФГУП "ГосНИИгенетика" | Method for obtaining spore material of bacteria of clostridium type |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2054643B (en) * | 1979-07-18 | 1983-05-05 | Rolls Royce | Fermentation process for the manufacture of an organic compound |
| US4292406A (en) * | 1979-09-11 | 1981-09-29 | The United States Of America As Represented By The United States Department Of Energy | Anaerobic thermophilic culture system |
| US4652526A (en) * | 1981-07-29 | 1987-03-24 | The Curators Of The University Of Missouri | Ethanol-producing mutants of Clostridium thermosaccharolyticum |
| US4778760A (en) * | 1984-11-09 | 1988-10-18 | Hitachi, Ltd. | Thermostable α-amylase-producing, thermophilic anaerobic bacteria, thermostable α-amylase and process for producing the same |
-
1991
- 1991-05-24 US US07/707,177 patent/US5158887A/en not_active Expired - Fee Related
- 1991-09-09 JP JP3257013A patent/JPH04356186A/en active Pending
- 1991-11-13 WO PCT/US1991/008487 patent/WO1992020782A1/en not_active Ceased
- 1991-11-13 RU RU9193058644A patent/RU2091483C1/en active
- 1991-11-13 BR BR9107308A patent/BR9107308A/en not_active IP Right Cessation
- 1991-11-13 AU AU12422/92A patent/AU669477B2/en not_active Ceased
- 1991-11-13 CA CA002109808A patent/CA2109808A1/en not_active Abandoned
-
1992
- 1992-12-04 EP EP19920904655 patent/EP0587566A4/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| RU2091483C1 (en) | 1997-09-27 |
| WO1992020782A1 (en) | 1992-11-26 |
| AU1242292A (en) | 1992-12-30 |
| BR9107308A (en) | 1994-06-28 |
| US5158887A (en) | 1992-10-27 |
| EP0587566A4 (en) | 1994-12-07 |
| EP0587566A1 (en) | 1994-03-23 |
| CA2109808A1 (en) | 1992-11-26 |
| JPH04356186A (en) | 1992-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Svetlitchnyi et al. | Single-step ethanol production from lignocellulose using novel extremely thermophilic bacteria | |
| Jesse et al. | Production of butanol from starch-based waste packing peanuts and agricultural waste | |
| Zeikus et al. | Thermoanaerobium brockii gen. nov. and sp. nov., a new chemoorganotrophic, caldoactive, anaerobic bacterium | |
| McBee | The anaerobic thermophilic cellulolytic bacteria | |
| Mori | Characterization of a symbiotic coculture of Clostridium thermohydrosulfuricum YM3 and Clostridium thermocellum YM4 | |
| CA1142464A (en) | Anaerobic thermophilic culture system | |
| Wang et al. | Ethanol from cellulosic biomass | |
| US4568644A (en) | Fermentation method producing ethanol | |
| Maki | Experiments on the microbiology of cellulose decomposition in a municipal sewage plant | |
| CN101981199A (en) | Methods for the conversion of plant materials into fuels and chemicals by sequential action of two microorganisms | |
| WO2010104896A1 (en) | Production of fermentive end products from clostridium sp. | |
| Murray | Symbiotic relationship of Bacteroides cellulosolvens and Clostridium saccharolyticum in cellulose fermentation | |
| CN100338221C (en) | Preparation of lactic acid from a pentose-containing substrate | |
| EP2872616B1 (en) | Methods and microbial cultures for improved conversion of lignocellulosic biomass | |
| AU669477B2 (en) | Process for massive conversion of clostridia into synchronized cells of critical length or refractile endospores | |
| Ravinder et al. | Clostridium lentocellum SG6–a potential organism for fermentation of cellulose to acetic acid | |
| Sai Ram et al. | Production of ethanol from straw and bamboo pulp by primary isolates of Clostridium thermocellum | |
| RU2080382C1 (en) | Strain of bacterium clostridium acetobutylicum - a producer of normal butyl alcohol and acetone | |
| US9970016B2 (en) | Genetic engineered bacteria and methods for promoting production of succinic acid or lactic acid | |
| TWI719317B (en) | Method for producing lactic acid | |
| US20130210071A1 (en) | Consolidated bioprocessing method using thermophilic microorganisms | |
| WO2010037018A2 (en) | Selection of cellulolytic microbes with high growth rates | |
| Le Ruyet et al. | Thermophilic fermentation of cellulose and xylan by methanogenic enrichment cultures: preliminary characterization of main species | |
| US20120264183A1 (en) | Cellulose and Xylan Fermentation by Novel Anaerobic Thermophilic Clostridia Isolated From Self-Heated Biocompost | |
| WO2010024715A1 (en) | Strain of clostridium acetobutylicum and method of producing organic solvents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |